MENU
+Compare
ANIP
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$57.94
Change
-$1.73 (-2.90%)
Capitalization
1.43B

ANIP ANI Pharmaceuticals Forecast, Technical & Fundamental Analysis

a manufacturer of branded and generic prescription pharmaceuticals

ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ANIP with price predictions
Feb 21, 2025

ANIP's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for ANIP moved out of overbought territory on January 28, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 instances where the indicator moved out of the overbought zone. In of the 27 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where ANIP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on February 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ANIP as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ANIP turned negative on February 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 61 similar instances when the indicator turned negative. In of the 61 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ANIP broke above its upper Bollinger Band on January 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

ANIP moved above its 50-day moving average on January 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ANIP crossed bullishly above the 50-day moving average on January 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIP advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 190 cases where ANIP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANIP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.305) is normal, around the industry mean (59.993). P/E Ratio (79.847) is within average values for comparable stocks, (90.174). ANIP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (2.537) is also within normal values, averaging (19.928).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANIP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ANIP is expected to report earnings to rise 8.21% to $1.45 per share on February 28

ANI Pharmaceuticals ANIP Stock Earnings Reports
Q4'24
Est.
$1.45
Q3'24
Beat
by $0.26
Q2'24
Beat
by $0.07
Q1'24
Beat
by $0.23
Q4'23
Beat
by $0.14
The last earnings report on November 08 showed earnings per share of $1.34, beating the estimate of $1.08. With 218.47K shares outstanding, the current market capitalization sits at 1.43B.
A.I. Advisor
published General Information

General Information

a manufacturer of branded and generic prescription pharmaceuticals

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
210 Main Street West
Phone
+1 218 634-3500
Employees
642
Web
https://www.anipharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRBX41.17-0.12
-0.29%
MFS International Growth B
FHLSX10.43-0.04
-0.38%
Fidelity Health Savings
PGDRX11.36-0.10
-0.87%
Principal Diversified Real Asset R3
FGILX21.33-0.24
-1.11%
Fidelity Global Equity Income
ATWAX22.83-0.37
-1.59%
AB Tax-Managed Wealth Apprec Strat A

ANIP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with DRRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-2.90%
DRRX - ANIP
38%
Loosely correlated
-1.36%
SNDL - ANIP
31%
Poorly correlated
+0.57%
PRPH - ANIP
29%
Poorly correlated
-9.49%
ORGO - ANIP
26%
Poorly correlated
-5.03%
AMRX - ANIP
25%
Poorly correlated
-0.51%
More